Exportar Publicação

Peralta, R., Rafaela Rocha, Ana Sofia Dias, Fazendeiro, J., Ponce, P., Ana Bernardo...Filipe Cristóvão (2026). A Randomized Control Trial of MuST for Vascular Access Cannulation in Hemodialysis Patients: Contributions for a Safe Nursing Intervention. Kidney Medicine. 8 (5), 101305

R. Peralta et al.,  "A Randomized Control Trial of MuST for Vascular Access Cannulation in Hemodialysis Patients: Contributions for a Safe Nursing Intervention", in Kidney Medicine, vol. 8, no. 5, pp. 101305, 2026

@article{peralta2026_1775833538679,
	author = "Peralta, R. and Rafaela Rocha and Ana Sofia Dias and Fazendeiro, J. and Ponce, P. and Ana Bernardo and Wammi, A and Manuela Stauss-Grabo and Stefano Stuard and Marjelka Trkulja and Carvalho, H. and Dias, O. and Filipe Cristóvão",
	title = "A Randomized Control Trial of MuST for Vascular Access Cannulation in Hemodialysis Patients: Contributions for a Safe Nursing Intervention",
	journal = "Kidney Medicine",
	year = "2026",
	volume = "8",
	number = "5",
	doi = "10.1016/j.xkme.2026.101305",
	pages = "101305"
}

TY  - JOUR
TI  - A Randomized Control Trial of MuST for Vascular Access Cannulation in Hemodialysis Patients: Contributions for a Safe Nursing Intervention
T2  - Kidney Medicine
VL  - 8
IS  - 5
AU  - Peralta, R.
AU  - Rafaela Rocha
AU  - Ana Sofia Dias
AU  - Fazendeiro, J.
AU  - Ponce, P.
AU  - Ana Bernardo
AU  - Wammi, A
AU  - Manuela Stauss-Grabo
AU  - Stefano Stuard
AU  - Marjelka Trkulja
AU  - Carvalho, H.
AU  - Dias, O.
AU  - Filipe Cristóvão
PY  - 2026
SP  - 101305
SN  - 2590-0595
DO  - 10.1016/j.xkme.2026.101305
AB  - Intervention: The intervention group received MuST, while the control group
underwent RL, with both groups followed for period of 12 months
Outcomes: The primary outcome was to evaluate the AVF survival rate at 12 months,
defined as unassisted patency. The secondary outcome included the assessment of
assisted primary patency, complication rates, and pain perception.
Results: There were no statistically significant differences between the MuST and RL
techniques in unassisted patency (HR = 1.02, 95% CI = 0.38, 2.71, p = 0.98) or in
assisted patency (HR = 0.74; 95% CI = 0.37, 1.47, p = 0.39).
There were no statistically significant differences in the incidence of haematoma or
thrombosis, and no infections occurred during the study period. The MuST presented an
advantage over RL in the development and new aneurysms formation. There were no
significant differences observed in pain perception between the two cannulation
techniques.
Limitations: The sample size was smaller than expected due to limitations in the
selection of patients during the SARS-CoV-2 pandemic phase.
Conclusions: We could not definitively demonstrate a difference in AVF survival
between MuST and RL. The low incidence of AVF thrombosis in both techniques
shows that MuST can be a choice in patient safety and well-being when nursing teams
decide which cannulation technique to perform.
Trial Registration: Registered at ClinicalTrials.gov with study number NCT05081648
ER  -